THERAVET revenue for the last year amounted to 117.84 k EUR, the most of which — 117.84 k EUR — came from its highest performing source at the moment, Osteoarticular Treatment, the year earlier bringing 94.04 k EUR. The greatest contribution to the revenue figure was made by Europe — last year it brought THERAVET 85.89 k EUR.